US Stock MarketDetailed Quotes

Praxis Precision Medicines (PRAX)

Watchlist
  • 304.380
  • -8.220-2.63%
Close Jan 22 16:00 ET
  • 304.300
  • -0.080-0.03%
Post 20:01 ET
8.34BMarket Cap-23.47P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Praxis Precision Medicines (PRAX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-136.57%-65.06M
-100.44%-54.68M
-154.16%-53.01M
-18.55%-131.76M
-135.20%-56.12M
-18.46%-27.5M
12.61%-27.28M
36.50%-20.86M
39.94%-111.14M
17.17%-23.86M
Net income from continuing operations
-42.43%-73.93M
-117.67%-71.13M
-75.20%-69.3M
-48.30%-182.82M
-118.32%-58.68M
-110.74%-51.91M
4.77%-32.68M
-5.60%-39.55M
42.40%-123.28M
34.72%-26.88M
Depreciation and amortization
-79.35%19K
-57.01%46K
-58.04%47K
-17.13%358K
-57.66%47K
-15.60%92K
0.94%107K
5.66%112K
3.10%432K
5.71%111K
Other non cash items
11.44%263K
11.74%257K
-90.86%249K
310.16%3.43M
11.47%243K
11.32%236K
11.65%230K
1,255.22%2.72M
11.30%837K
11.22%218K
Change In working capital
-86.43%1.85M
1,209.79%9.37M
474.06%8.43M
177.83%10.92M
-61.88%-4.92M
392.59%13.66M
123.91%715K
144.03%1.47M
-687.87%-14.03M
-155.20%-3.04M
-Change in prepaid assets
-175.95%-1.38M
162.36%280K
921.41%6.64M
-221.46%-8.23M
-557.37%-8.79M
-44.60%1.82M
-114.72%-449K
-145.62%-808K
1,138.03%6.77M
24.85%-1.34M
-Change in payables and accrued expense
-71.29%3.57M
421.77%9.4M
-29.52%2.1M
231.53%22.82M
707.89%5.62M
271.71%12.42M
135.94%1.8M
171.25%2.98M
-163.99%-17.35M
-136.76%-925K
-Change in other current liabilities
-11.54%-319K
-11.87%-311K
-11.81%-303K
-12.04%-1.13M
-11.49%-291K
-12.60%-286K
-11.20%-278K
-12.92%-271K
-23.92%-1.01M
-12.02%-261K
-Change in other working capital
96.64%-10K
99.72%-1K
99.54%-2K
-4.25%-2.55M
-183.69%-1.46M
36.32%-298K
54.03%-359K
36.60%-433K
-148.40%-2.45M
-110.30%-515K
Cash from discontinued investing activities
Operating cash flow
-136.57%-65.06M
-100.44%-54.68M
-154.16%-53.01M
-18.55%-131.76M
-135.20%-56.12M
-18.46%-27.5M
12.61%-27.28M
36.50%-20.86M
39.94%-111.14M
17.17%-23.86M
Investing cash flow
Cash flow from continuing investing activities
1.71%50.41M
109.13%17.89M
44.02%-51.06M
-737.98%-248.49M
-21,736.00%-10.92M
49.57M
-4,018.44%-195.92M
-368.29%-91.22M
-59.80%38.95M
-100.22%-50K
Net PPE purchase and sale
--0
----
----
--0
--0
--0
----
----
88.74%-50K
----
Net investment purchase and sale
1.71%50.41M
109.16%17.95M
44.02%-51.06M
-737.16%-248.49M
---10.92M
--49.57M
-4,018.44%-195.92M
-368.29%-91.22M
-59.93%39M
--0
Cash from discontinued investing activities
Investing cash flow
1.71%50.41M
109.13%17.89M
44.02%-51.06M
-737.98%-248.49M
-21,736.00%-10.92M
--49.57M
-4,018.44%-195.92M
-368.29%-91.22M
-59.80%38.95M
-100.22%-50K
Financing cash flow
Cash flow from continuing financing activities
370.47%6.76M
-86.77%28.63M
-70.31%54.27M
459.83%514.32M
2,657.32%113.77M
1.44M
210.53%216.36M
911.38%182.76M
777.89%91.87M
-23.41%4.13M
Net common stock issuance
385.44%6M
-86.87%28.36M
-69.96%54.9M
459.00%512M
2,681.37%111.95M
--1.24M
211.01%216.06M
909.90%182.75M
857.98%91.59M
-23.05%4.03M
Proceeds from stock option exercised by employees
301.99%808K
-6.67%294K
291.61%560K
532.93%2.63M
1,762.26%1.97M
20,000.00%201K
51.44%315K
41.58%143K
-70.83%416K
-34.97%106K
Net other financing activities
-5,100.00%-52K
-76.92%-23K
-772.26%-1.2M
-124.82%-308K
-3,040.00%-157K
0.00%-1K
-225.00%-13K
-7.87%-137K
73.75%-137K
28.57%-5K
Cash from discontinued financing activities
Financing cash flow
370.47%6.76M
-86.77%28.63M
-70.31%54.27M
459.83%514.32M
2,657.32%113.77M
--1.44M
210.53%216.36M
911.38%182.76M
777.89%91.87M
-23.41%4.13M
Net cash flow
Beginning cash position
8.43%157.83M
8.92%165.98M
164.07%215.79M
31.73%81.72M
66.56%169.06M
16.71%145.56M
87.55%152.4M
31.73%81.72M
-55.60%62.03M
61.48%101.5M
Current changes in cash
-133.56%-7.89M
-19.23%-8.15M
-170.47%-49.81M
581.09%134.07M
336.17%46.73M
201.24%23.5M
-115.73%-6.84M
267.67%70.68M
125.34%19.69M
-2,298.18%-19.79M
End cash Position
-11.31%149.94M
8.43%157.83M
8.92%165.98M
164.07%215.79M
164.07%215.79M
66.56%169.06M
16.71%145.56M
87.55%152.4M
31.73%81.72M
31.73%81.72M
Free cash flow
-136.57%-65.06M
-100.65%-54.73M
-154.16%-53.01M
-18.50%-131.76M
-134.71%-56.12M
-18.46%-27.5M
12.61%-27.28M
36.50%-20.86M
40.06%-111.19M
16.99%-23.91M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -136.57%-65.06M-100.44%-54.68M-154.16%-53.01M-18.55%-131.76M-135.20%-56.12M-18.46%-27.5M12.61%-27.28M36.50%-20.86M39.94%-111.14M17.17%-23.86M
Net income from continuing operations -42.43%-73.93M-117.67%-71.13M-75.20%-69.3M-48.30%-182.82M-118.32%-58.68M-110.74%-51.91M4.77%-32.68M-5.60%-39.55M42.40%-123.28M34.72%-26.88M
Depreciation and amortization -79.35%19K-57.01%46K-58.04%47K-17.13%358K-57.66%47K-15.60%92K0.94%107K5.66%112K3.10%432K5.71%111K
Other non cash items 11.44%263K11.74%257K-90.86%249K310.16%3.43M11.47%243K11.32%236K11.65%230K1,255.22%2.72M11.30%837K11.22%218K
Change In working capital -86.43%1.85M1,209.79%9.37M474.06%8.43M177.83%10.92M-61.88%-4.92M392.59%13.66M123.91%715K144.03%1.47M-687.87%-14.03M-155.20%-3.04M
-Change in prepaid assets -175.95%-1.38M162.36%280K921.41%6.64M-221.46%-8.23M-557.37%-8.79M-44.60%1.82M-114.72%-449K-145.62%-808K1,138.03%6.77M24.85%-1.34M
-Change in payables and accrued expense -71.29%3.57M421.77%9.4M-29.52%2.1M231.53%22.82M707.89%5.62M271.71%12.42M135.94%1.8M171.25%2.98M-163.99%-17.35M-136.76%-925K
-Change in other current liabilities -11.54%-319K-11.87%-311K-11.81%-303K-12.04%-1.13M-11.49%-291K-12.60%-286K-11.20%-278K-12.92%-271K-23.92%-1.01M-12.02%-261K
-Change in other working capital 96.64%-10K99.72%-1K99.54%-2K-4.25%-2.55M-183.69%-1.46M36.32%-298K54.03%-359K36.60%-433K-148.40%-2.45M-110.30%-515K
Cash from discontinued investing activities
Operating cash flow -136.57%-65.06M-100.44%-54.68M-154.16%-53.01M-18.55%-131.76M-135.20%-56.12M-18.46%-27.5M12.61%-27.28M36.50%-20.86M39.94%-111.14M17.17%-23.86M
Investing cash flow
Cash flow from continuing investing activities 1.71%50.41M109.13%17.89M44.02%-51.06M-737.98%-248.49M-21,736.00%-10.92M49.57M-4,018.44%-195.92M-368.29%-91.22M-59.80%38.95M-100.22%-50K
Net PPE purchase and sale --0----------0--0--0--------88.74%-50K----
Net investment purchase and sale 1.71%50.41M109.16%17.95M44.02%-51.06M-737.16%-248.49M---10.92M--49.57M-4,018.44%-195.92M-368.29%-91.22M-59.93%39M--0
Cash from discontinued investing activities
Investing cash flow 1.71%50.41M109.13%17.89M44.02%-51.06M-737.98%-248.49M-21,736.00%-10.92M--49.57M-4,018.44%-195.92M-368.29%-91.22M-59.80%38.95M-100.22%-50K
Financing cash flow
Cash flow from continuing financing activities 370.47%6.76M-86.77%28.63M-70.31%54.27M459.83%514.32M2,657.32%113.77M1.44M210.53%216.36M911.38%182.76M777.89%91.87M-23.41%4.13M
Net common stock issuance 385.44%6M-86.87%28.36M-69.96%54.9M459.00%512M2,681.37%111.95M--1.24M211.01%216.06M909.90%182.75M857.98%91.59M-23.05%4.03M
Proceeds from stock option exercised by employees 301.99%808K-6.67%294K291.61%560K532.93%2.63M1,762.26%1.97M20,000.00%201K51.44%315K41.58%143K-70.83%416K-34.97%106K
Net other financing activities -5,100.00%-52K-76.92%-23K-772.26%-1.2M-124.82%-308K-3,040.00%-157K0.00%-1K-225.00%-13K-7.87%-137K73.75%-137K28.57%-5K
Cash from discontinued financing activities
Financing cash flow 370.47%6.76M-86.77%28.63M-70.31%54.27M459.83%514.32M2,657.32%113.77M--1.44M210.53%216.36M911.38%182.76M777.89%91.87M-23.41%4.13M
Net cash flow
Beginning cash position 8.43%157.83M8.92%165.98M164.07%215.79M31.73%81.72M66.56%169.06M16.71%145.56M87.55%152.4M31.73%81.72M-55.60%62.03M61.48%101.5M
Current changes in cash -133.56%-7.89M-19.23%-8.15M-170.47%-49.81M581.09%134.07M336.17%46.73M201.24%23.5M-115.73%-6.84M267.67%70.68M125.34%19.69M-2,298.18%-19.79M
End cash Position -11.31%149.94M8.43%157.83M8.92%165.98M164.07%215.79M164.07%215.79M66.56%169.06M16.71%145.56M87.55%152.4M31.73%81.72M31.73%81.72M
Free cash flow -136.57%-65.06M-100.65%-54.73M-154.16%-53.01M-18.50%-131.76M-134.71%-56.12M-18.46%-27.5M12.61%-27.28M36.50%-20.86M40.06%-111.19M16.99%-23.91M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -